HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

margaric acid (heptadecanoic acid)

RN given refers to unlabeled parent cpd
Also Known As:
heptadecanoic acid; margaric acid, 1-(11)C-labeled; margaric acid, nickel (2+) salt; margaric acid, potassium salt; margaric acid, sodium salt; omega I-123 heptadecanoic acid
Networked: 51 relevant articles (0 outcomes, 13 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Carpentier, André C: 6 articles (01/2022 - 07/2006)
2. Guérin, Brigitte: 5 articles (01/2022 - 02/2011)
3. Noll, Christophe: 4 articles (01/2022 - 11/2012)
4. Phoenix, Serge: 4 articles (01/2022 - 11/2012)
5. Turcotte, Eric E: 4 articles (07/2015 - 02/2011)
6. Frisch, Frédérique: 3 articles (01/2022 - 07/2006)
7. Iozzo, Patricia: 3 articles (01/2015 - 07/2004)
8. Nuutila, Pirjo: 3 articles (01/2015 - 07/2004)
9. Grenier-Larouche, Thomas: 3 articles (06/2014 - 02/2011)
10. Labbé, Sébastien M: 3 articles (06/2014 - 02/2011)

Related Diseases

1. Glucose Intolerance
07/01/2004 - "Hepatic FFA influx rate constant (LKi) was measured after a 12-15-h fast in 10 patients with impaired glucose tolerance (IGT) and eight control subjects using positron emission tomography in combination with the long-chain FFA analog 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. "
06/01/1999 - "Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid."
07/01/2015 - "Oral 14(R,S)-[(18)F]-fluoro-6-thia-heptadecanoic acid was used to determine whether an increase in cardiac dietary fatty acid (DFA) metabolism in impaired glucose tolerance (IGT) is different in men and women. "
06/15/2014 - "Using a novel positron emission tomography (PET) method with oral administration of 14(R,S)-[¹⁸F]-fluoro-6-thia-heptadecanoic acid (¹⁸FTHA), we recently demonstrated that subjects with impaired glucose tolerance (IGT) display an impairment in cardiac function associated with increased myocardial uptake of dietary fatty acids. "
11/01/2012 - "Using a recently validated positron emission tomography (PET) imaging method with 14(R,S)-[(¹⁸F]-fluoro-6-thia-heptadecanoic acid to quantify organ-specific dietary fatty acid partitioning, we demonstrate in this study that overweight and obese subjects with impaired glucose tolerance (IGT⁺) display significant increase in fractional myocardial dietary fatty acid uptake over the first 6 h postprandial compared with control individuals (IGT⁻). "
2. Myocardial Infarction
3. Overweight
4. Cardiovascular Diseases (Cardiovascular Disease)
5. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. pentadecanoic acid
2. Fatty Acids (Saturated Fatty Acids)
3. 14-fluoro-6-thiaheptadecanoic acid
4. Biomarkers (Surrogate Marker)
5. Nonesterified Fatty Acids (NEFA)
6. Glucose (Dextrose)
7. Acids
8. Palmitic Acid (Hexadecanoic Acid)
9. Palmitates
10. Esters

Related Therapies and Procedures

1. Thrombolytic Therapy
2. Oral Administration